Special Issue "Bioactive Compounds from Marine Microbes"

Quicklinks

A special issue of Marine Drugs (ISSN 1660-3397).

Deadline for manuscript submissions: closed (31 July 2011)

Special Issue Editor

Guest Editor
Dr. Kirk R. Gustafson
Molecular Targets Laboratory, Center for Cancer Research, National Cancer Institute, Building 1052, Room 121, Frederick, MD 21702-1201, USA
Website: http://ccr.cancer.gov/staff/staff.asp?profileid=7125
E-Mail:
Phone: +1 301 846 5197
Fax: +1 301 846 6157
Interests: natural products chemistry; chemical biology of natural products; NMR spectroscopy

Published Papers

Special Issue Information

Dear Colleagues,

The marine environment is a vast and largely unexplored resource for accessing diverse communities of microorganisms with novel biosynthetic capabilities. Marine habitats provide unique conditions for microbial growth and secondary metabolite expression that are not found in terrestrial ecosystems. The co-evolution of many marine macroorganisms, particularly invertebrate animals, with these microbes has often lead to the development of very close associations or symbiotic relationships between the host organism and a specific microbe. This in turn has resulted in the development and elaboration of unique microbial biosynthetic pathways and capabilities that can be utilized to generate novel compounds. Marine sediments are also now recognized as a rich source of microbial taxonomic diversity and new biologically active compounds. Efforts to cultivate and evaluate marine microorganisms and the associated compounds they can produce have expanded significantly in recent years, but this are of study is still very much in its infancy considering the vastness of the marine environment and the different types of microbial habitats found there.

Kirk R. Gustafson Ph. D.
Guest Editor

Submission

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. Papers will be published continuously (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are refereed through a peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed Open Access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1600 CHF (Swiss Francs).


Keywords

  • actinomycetes
  • bacteria
  • biosynthesis
  • dereplication
  • fungi
  • metabolic modulators and elicitors
  • micro algae
  • quorum sensing
  • symbionts

Last update: 11 February 2011

Mar. Drugs EISSN 1660-3397 Published by MDPI Publishing, Basel, Switzerland RSS E-Mail Table of Contents Alert